E. Reiter

CD44 is a determinant of inflammatory bone loss

E. Wagner, J. Zwerina, G. Schett, 2005, The Journal of experimental medicine.

Zoledronic acid protects from local and systemic bone loss in tumor necrosis factor-mediated arthritis

H. Bergmeister, J. Smolen, G. Schett, 2004, Arthritis Research & Therapy.

Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis.

H. Bergmeister, G. Schett, J. Smolen, 2004, Arthritis and rheumatism.

CD44 is a determinant of inflammatory bone loss

E. Wagner, J. Zwerina, G. Schett, 2005, The Journal of experimental medicine.

Zoledronic acid protects from local and systemic bone loss in tumor necrosis factor-mediated arthritis

H. Bergmeister, G. Schett, J. Smolen, 2004 .